衰老细胞因高频副甲状腺激素1 - 34的使用和骨质损失导致骨微观结构的恶化
Masayuki Bun1, Yuichiro Ukon1, Masato Ikuta1
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Aging cell
|December 23, 2025
概括
用老化剂向细胞衰老可以减轻在老年小鼠上甲状腺激素 (PTH) 治疗后的骨损失. 这种方法可以提高骨质疏松症治疗的长期有效性.
科学领域:
- 老年学是一门学科.
- 骨生物学 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症是一种骨质减少和结构恶化的疾病,增加骨折风险,特别是在老年人中.
- 副甲状腺激素 (PTH) 是一种用于骨质疏松症的合成代谢疗法,但在停止治疗后会出现快速的骨质损失.
- 细胞衰老与与年龄相关的骨脆弱性有关,但其在PTH治疗和治疗后骨损失中的作用尚不清楚.
研究的目的:
- 研究PTH施用频率对年轻和老年小鼠骨微观架构和细胞衰老的影响.
- 为了确定是否向衰老细胞可以在老年小鼠的PTH治疗期间和之后改善结果.
主要方法:
- 给年轻和老年小鼠以不同的频率给药PTH.
- 评估了骨微观结构,骨质细胞活动和衰老细胞负担.
- 在老年小鼠中与PTH同时服用老化剂 (达沙替尼和奎尔塞丁).
主要成果:
- 高频PTH在老年小鼠中改善了椎骨,但恶化了皮质骨和增加了骨质细胞活性.
- 在老年小鼠中,PTH增加了衰老的骨质母细胞系细胞和mTORC1通路激活.
- 在老年小鼠中,老化药物减少了衰老细胞,改善了皮质多孔性,并在PTH停止后预防了骨损失.
结论:
- 衰老的骨质母细胞血统细胞有助于老年人的骨脆弱性和治疗后的骨损失.
- 向衰老可能会提高骨质疏松症PTH治疗的疗效和耐久性.
- 老龄化药物提供了一种潜在的策略,以改善PTH的长期骨质疏松症管理.
更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
12.1K
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
18.4K
相关概念视频
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
What is the Skeletal System?
56.6K
Overview
56.6K
Skeleton and Calcium Homeostasis
5.7K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
5.7K
